SARS-CoV-2 Envelope Protein (C40A, C43A, C44A mutant, recombinant)

SARS-CoV-2 Envelope Protein (C40A, C43A, C44A mutant, recombinant)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay40875-100 100 µg - -

5 - 10 Werktage*

685,00 €
 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped positive-stranded... mehr
Produktinformationen "SARS-CoV-2 Envelope Protein (C40A, C43A, C44A mutant, recombinant)"
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped positive-stranded RNA virus, a member of the Betacoronavirus genus, and the causative agent of COVID-19. The SARS-CoV-2 genome contains approximately 30 kilobases and 14 open reading frames (ORFs) that encode four structural proteins: spike, envelope, membrane, and nucleocapsid, as well as 16 non-structural proteins and nine accessory factors. The SARS-CoV-2 envelope protein (E protein) is composed of an N-terminal domain, a transmembrane domain, and a C-terminal domain, which contains three conserved cysteine residues (C40, C43, and C44) that are post-translationally palmitoylated in a similar virus, SARS-CoV. It localizes to the Golgi, endoplasmic reticulum (ER), and ER-Golgi intermedium compartment (ERGIC) of SARS-CoV-2 infected cells and homo-oligomerization of the E protein forms a pH-sensitive, cation-selective ion channel, also known as a viroporin. It is involved in morphogenesis, viral assembly, and maturation and retention of the spike glycoprotein, also known as surface glycoprotein. SARS-CoV-2 E protein is acetylated by the histone acetyltransferase p300, and acetylated SARS-CoV-2 E protein binds to bromodomain-containing protein 4 (BRD4). Intravenous administration of recombinant SARS-CoV-2 E protein induces spleen edema, as well as pulmonary inflammatory cell infiltration, edema, interstitial hyperemia, hemorrhage, and alveolar collapse in mice. Cayman's SARS-CoV-2 Envelope Protein (C40A, C43A, C44A mutant, recombinant) protein consists of 475 amino acids and has a calculated molecular weight of 52.2 kDa.Synonyms: SARS-CoV-2 E Protein, SARS-CoV-2 Envelope Small Membrane Protein, SARS-CoV-2 sM Protein, Severe Acute Respiratory Syndrome Coronavirus 2 Envelope Protein. Purity: >90% estimated by SDS-PAGE. Source: Recombinant SARS-CoV-2 N-terminal His- and MBP-tagged E protein (C40A, C43A, C44A mutant) expressed in E. coli. Amino Acids: 1-475. MW: 52.2 kDa. Formulation: (Request formulation change), Lyophilized from sterile PBS, pH 7.4. UniProt Accession #: P0DTC4.
Schlagworte: 4, E, E, sM protein, sM protein, Envelope small membrane protein, Envelope small membrane protein
Hersteller: Cayman Chemical
Hersteller-Nr: 40875

Eigenschaften

Konjugat: No
Wirt: E.coli
Spezies-Reaktivität: SARS-CoV-2
Reinheit: >90% (SDS-PAGE)
Format: Lyophilized

Handhabung & Sicherheit

Lagerung: -80°C
Versand: -80°C (International: -80°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "SARS-CoV-2 Envelope Protein (C40A, C43A, C44A mutant, recombinant)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen